Marex Group PLC Adagene Inc. Transaction History
Marex Group PLC
- $11.1 Billion
- Q2 2025
A detailed history of Marex Group PLC transactions in Adagene Inc. stock. As of the latest transaction made, Marex Group PLC holds 24,000 shares of ADAG stock, worth $44,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,000Holding current value
$44,640% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADAG
# of Institutions
14Shares Held
9.67MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$7.41 Million46.44% of portfolio
-
General Atlantic LLC New York, NY3.83MShares$7.12 Million0.26% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$2.5 Million0.16% of portfolio
-
Mill Creek Capital Advisors, LLC Conshohocken, PA200KShares$371,2740.01% of portfolio
-
Kamunting Street Capital Management, L.P. Miami Beach, FL126KShares$234,4190.22% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $80.8M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...